A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany

InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2

NCT05835739 ·Status: RECRUITING

Tumour Registry Breast Cancer

NCT01351584 ·Status: COMPLETED

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

NCT06708910 ·Status: RECRUITING

Breast Cancer Registry Platform

NCT03417115 ·Status: ACTIVE_NOT_RECRUITING

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

NCT00666731 ·Status: COMPLETED

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

NCT04480814 ·Status: COMPLETED

Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 ·Status: COMPLETED

A Study of Patients With HER2-Positive Metastatic Breast Cancer

NCT00105456 ·Status: COMPLETED

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

NCT06551116 ·Status: RECRUITING

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

NCT04365790 ·Status: UNKNOWN

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

NCT03401034 ·Status: COMPLETED

A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer

NCT00477139 ·Status: COMPLETED

Breast Cancer Proteomics and Molecular Heterogeneity

NCT01840293 ·Status: RECRUITING

An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya

NCT01484483 ·Status: COMPLETED

A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

NCT03655353 ·Status: RECRUITING ·Phase: NA

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

NCT02244580 ·Status: COMPLETED ·Phase: NA

Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CT

NCT02798562 ·Status: UNKNOWN ·Phase: NA

Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

NCT07292571 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Follow-up in Early and Locally Advanced Breast Cancer Patients

NCT03859453 ·Status: COMPLETED

Immunomonitoring of Breast Cancer Patients During Systemic Treatment

NCT04925856 ·Status: RECRUITING ·Phase: NA

Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer

NCT04246606 ·Status: COMPLETED

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

NCT01407770 ·Status: COMPLETED

Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

NCT07056205 ·Status: ENROLLING_BY_INVITATION

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

NCT01839045 ·Status: UNKNOWN

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

NCT05466786 ·Status: RECRUITING